Latest debt-to-equity ratio
Lakewood-Amedex Biotherapeutics Debt-to-equity ratio
Direct answer
Lakewood-Amedex Biotherapeutics's debt-to-equity ratio is 2.35%.
The verified market snapshot reports 2.35%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 27, 2026.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.35%
Explore related company data
View Lakewood-Amedex Biotherapeutics's market capitalizationView Lakewood-Amedex Biotherapeutics's price-to-book ratioView Lakewood-Amedex Biotherapeutics's return on equityView Lakewood-Amedex Biotherapeutics's 52-week price rangeView Lakewood-Amedex Biotherapeutics's profit marginView all Lakewood-Amedex Biotherapeutics key metricsReturn to Lakewood-Amedex Biotherapeutics profile